{"id":"NCT01513473","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus","officialTitle":"A 26-week, Multinational, Multi-centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Degludec and Insulin Detemir in Children and Adolescents 1 to Less Than 18 Years With Type 1 Diabetes Mellitus on a Basal-bolus Regimen With Insulin Aspart as Bolus Insulin, Followed by a 26-week Extension Investigating Long Term Safety (BEGINâ„¢: Young 1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01-16","primaryCompletion":"2013-07-30","completion":"2013-07-30","firstPosted":"2012-01-20","resultsPosted":"2016-01-12","lastUpdate":"2019-06-13"},"enrollment":350,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin detemir","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"Insulin Degludec + Insulin Aspart","type":"EXPERIMENTAL"},{"label":"Insulin Detemir +Insulin Aspart","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Africa, Asia, Europe and the United States of America (USA).\n\nThe aim of this trial is to investigate the efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin) (%) at 26 Weeks (Analysed by Central Laboratory)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"IDeg + IAsp","deltaMin":-0.2,"sd":0.95},{"arm":"IDet + IAsp","deltaMin":-0.31,"sd":0.89}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":81,"countries":["United States","Bulgaria","Finland","France","Germany","Italy","Japan","Netherlands","North Macedonia","Russia","South Africa","United Kingdom"]},"refs":{"pmids":["30666772","25683037"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":174},"commonTop":["Nasopharyngitis","Headache","Blood ketone body increased","Oropharyngeal pain","Cough"]}}